EVLO Shares Outstanding History



Below is a table of the EVLO shares outstanding history going back to 5/9/2018:

Date EVLO Shares Outstanding
5/9/20181.59M
5/30/20181.59M
7/31/20181.59M
10/30/20181.59M
2/8/20191.59M
4/30/20191.60M
7/31/20191.60M
8/8/20192.16M
10/31/20191.60M
2/7/20201.61M
5/5/20201.62M
7/27/20202.31M
10/28/20202.31M
3/5/20212.67M
4/27/20212.67M
7/26/20212.67M
10/26/20212.67M
3/21/20222.68M
5/9/20222.68M
8/8/20225.40M
11/8/20225.48M
5/8/20235.60M
8/10/202318.84M
11/6/202318.93M

Also see: EVLO Market Cap History
EVLO YTD Return
EVLO Historical Shares Outstanding:
+56.84% CAGR
EVLO Historical Shares Outstanding: +56.84% CAGR

Mouse over chart for data details
5/9/2018 ...11/6/2023
Evelo Biosciences is discovering and developing a class of medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body. The target cells in the small intestine play a role in governing human immune, metabolic and neurologic systems. Co.'s product candidates are orally delivered pharmaceutical preparations of naturally occurring, specific single strains of microbes or microbial extracellular vesicles. Co.'s product candidate, EDP1815, is being developed for the treatment of inflammatory diseases. Additional product candidates in development include EDP1867 and EDP2939 for the treatment of inflammatory disease. We show 24 historical shares outstanding datapoints in our coverage of EVLO's shares outstanding history.

Understanding the changing numbers of EVLO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like EVLO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching EVLO by allowing them to research EVLO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree EVLO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Evelo Biosciences (EVLO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

EVOK Shares Outstanding History
EW Shares Outstanding History
EWTX Shares Outstanding History
EXAS Shares Outstanding History
EXEL Shares Outstanding History
EYE Shares Outstanding History
EYEG Shares Outstanding History
EYEN Shares Outstanding History
EYES Shares Outstanding History
EYPT Shares Outstanding History
More Healthcare companies »

 

EVLO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.